Salt-inducible kinases (SIK) inhibition reduces RANKL-induced osteoclastogenesis

• Maria Stella Lombardi ,

  Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Supervision, Writing – original draft, Writing – review & editing

  * E-mail: cem.gabay@hcuge.ch (CGa); maria-stella.x.lombardi@gsk.com (MSL)

  Current address: GSK Consumer Healthcare-Department of Preclinical Development-Nyon, Switzerland

  Affiliations Division of Rheumatology, Department of Internal Medicine Specialties, University Hospitals of Geneva, Geneva, Switzerland, Department of Pathology and Immunology, University of Geneva School of Medicine, Geneva, Switzerland

  http://orcid.org/0000-0002-4105-7228

  ⨯
• Corine Gilliéron,

  Roles Formal analysis, Investigation, Methodology, Writing – original draft

  Affiliations Division of Rheumatology, Department of Internal Medicine Specialties, University Hospitals of Geneva, Geneva, Switzerland, Department of Pathology and Immunology, University of Geneva School of Medicine, Geneva, Switzerland

  ⨯
• Majoska Berkelaar,

  Roles Formal analysis, Investigation, Methodology

  Affiliations Division of Rheumatology, Department of Internal Medicine Specialties, University Hospitals of Geneva, Geneva, Switzerland, Department of Pathology and Immunology, University of Geneva School of Medicine, Geneva, Switzerland

  ⨯
• Cem Gabay

  Roles Conceptualization, Funding acquisition, Project administration, Supervision, Writing – review & editing

  * E-mail: cem.gabay@hcuge.ch (CGa); maria-stella.x.lombardi@gsk.com (MSL)

  Affiliations Division of Rheumatology, Department of Internal Medicine Specialties, University Hospitals of Geneva, Geneva, Switzerland, Department of Pathology and Immunology, University of Geneva School of Medicine, Geneva, Switzerland

  ⨯